Thank you for taking our quiz on allergic asthma! How did you do? 1) What percent of patients diagnosed with severe asthma (mean age of 12 years) were drug adherent, according to a study presented at AAAAI? a) 43% b) 57% c) 68%...
Read MoreThank you for taking our quiz on chronic urticaria! How did you do? 1) The NCBI recently released recommendations for diagnosis and management of chronic idiopathic urticaria, recommends using a skin prick test as part of...
Read More1) Results released from the Phase 3 CLEAR Trial found that lenvatinib combined with EITHER of these two drugs demonstrated significant benefits over sunitinib in patients with advanced RCC: a) pembrolizumab or...
Read MoreIn an interim analysis of the first immunotherapy combination phase 1b trial with trastuzumab deruxtecan, safety results showed nivolumab with trastuzumab deruxtecan was well tolerated in patients with HER2-positive or HER2-low...
Read MoreIn an updated analysis of the phase 2 DESTINY-Breast01 study, women with HER2-positive metastatic breast cancer taking antibody-drug conjugate trastuzumab deruxtecan continued to demonstrate favorable efficacy data, durable...
Read More
Researchers conducted a study to assess the medical and clinical changes patients with rheumatoid...
Read More
Psoriatic arthritis (PsA) is a heterogeneous disease which may precede, occur concurrently, or...
Read More
Despite numerous effective therapies for patients with psoriatic arthritis (PsA), many do not...
Read More
Guselkumab (GUS), a fully human monoclonal antibody, selectively binds and blocks IL-23. VOYAGE 1...
Read More
Ixekizumab (IXE) is a high affinity monoclonal antibody that selectively targets interleukin-17A....
Read MorePhysician’s Weekly spoke with first author Nicholas A. Marston, MD, an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital (Boston, USA), an Instructor of Medicine at Harvard Medical School, and an...
Read MoreHBM9036 ophthalmic solution 0.25%, also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...
Read MoreDry eye disease (DED) is a highly prevalent syndrome that manifests with symptoms that include constant irritation, burning or stinging sensations, and feelings of grittiness in the eyes. “DED is a chronic pain syndrome often...
Read MorePrevious research has shown that patients undergoing hematopoietic stem cell transplantation (HSCT) for hematologic malignancies, such as leukemia and lymphoma, are at a high risk of developing graft-versus-host disease (GVHD)....
Read MoreDry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability. The disease can significantly decrease quality of life as it impacts an...
Read More
Acute side-effects of radiation therapy (RT) are often underrecognized by the physicians of...
Read More
An online tool (RSClin) incorporating clinical-pathologic data and results of the 21-gene...
Read More
Meeting Brief… A subgroup of patients participating in the randomized phase III NALA study...
Read More
The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast...
Read More
Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to a systematic...
Read More
